D. E. Shaw & Co., Inc. Novan, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.29 - $3.86 $36,830 - $62,080	-16,083 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.95 - $4.41 $79,561 - $118,937	-26,970 Reduced 62.64%	16,083 $63,000
Q4 2021 Feb 14, 2022	BUY	$4.03 - $8.15 $173,503 - $350,881	43,053 New	43,053 $180,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.